Your session is about to expire
← Back to Search
Virtual Technology-Based Intervention for Colorectal Cancer Screening
Study Summary
This trial will test whether a patient-centered, tailored message intervention delivered via virtual technology can increase colorectal cancer screening among racial/ethnic minority and rural patients.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Non-FIT testing
- Group 2: Fit Testing
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants have been accepted to participate in this trial?
"Affirmative. The clinical trial database confirms that this research endeavour, which initially went up on November 8th 2018, is currently open for enrolment. Approximately 4000 people must be enrolled at 2 different sites."
Who qualifies to participate in this experimental trial?
"This clinical study seeks 4000 individuals aged between 45 and 73, who are diagnosed with colorectal carcinoma. Furthermore, the participants must possess an email address or access to text messages, agree to be contacted again in future, accept that their data is subject to CRC screening review protocols, not recall completing any recommended CRC screenings (such as a colonoscopy within 10 years or FIT test within 1 year) and have either negative results from tests only; completed a FIT test with positive outcome followed by completion of colonoscopy; or finished just one single colonoscopy procedure. Moreover they should comprehend English or Spanish at least on"
Is the eligibility criterion for this clinical study limited to those under 50 years of age?
"According to the stated eligibility criteria, candidates eligible for this trial must be between 45-73 years of age. 38 studies are available to those under 18 and 1050 studies have been created specifically with people over 65 in mind."
Does this trial have any open vacancies for participants?
"Confirmed, according to clinicaltrials.gov this trial is currently on the lookout for participants. It was formally announced on November 8th 2018 and last modified on March 2nd 2022."
Share this study with friends
Copy Link
Messenger